Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells - 12/09/12
, Tsipora Malachi a, Anat Gafter-Gvili b, c
Corresponding author. Department of Nephrology and Hypertension, Hasharon Hospital, 7, Keren Kayemet Street, 49372 Petah-Tikva, Israel. Tel.: +972 3 9372224; fax: +972 3 9372311.Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Introduction |
Immunosuppressive treatment increases the risk of post-transplant cancer. Cyclosporine reduced UV-induced DNA repair by peripheral blood mononuclear cells (PBMC) and increased cancer incidence in kidney transplant recipients. Calcineurin inhibitors (CNI), but not mammalian target of rapamycin (mTOR) inhibitors or mycophenolic acid, suppressed H2O2-induced DNA repair in human peripheral blood mononuclear cells (PBMC) in vitro at maintenance drug concentrations. DNA repair, when measured in quiescent cells, is named spontaneous DNA repair, and represents a basal ongoing DNA repair in response to endogenous DNA damage. The effect of immunosuppressive drugs on spontaneous DNA repair has not been investigated.
Aim |
To investigate the effect of currently used immunosuppressive drugs on spontaneous DNA repair.
Methods |
Spontaneous DNA repair by human PBMC was tested in vitro in the presence of the CNI–cyclosporine and tacrolimus; mycophenolic acid (MPA); and the mTOR inhibitors–sirolimus and everolimus, at low to high nontoxic concentrations.
Results |
Cyclosporine and tacrolimus suppressed spontaneous DNA repair throughout the tested dose range. In contrast, MPA, sirolimus and everolimus did so only at the high doses.
Conclusion |
A reduction in CNI dosage may lead to a decrease in the occurrence of post-transplant malignancy.
Le texte complet de cet article est disponible en PDF.Keywords : Calcineurin inhibitor, DNA repair, Immunosuppressive drugs, mTOR inhibitor, Mycophenolic acid
Plan
Vol 66 - N° 6
P. 409-413 - septembre 2012 Retour au numéro
Article précédent
- Ablation of the ATP-binding cassette transporter, Abca2 modifies response to estrogen-based therapies
- Jody T. Mack, Carol B. Brown, Tracy E. Garrett, Joachim D. Uys, Danyelle M. Townsend, Kenneth D. Tew
- Treatment of mild non-chemotherapy-induced iron deficiency anemia in cancer patients: Comparison between oral ferrous bisglycinate chelate and ferrous sulfate
- Paola Ferrari, Andrea Nicolini, Maria Laura Manca, Giuseppe Rossi, Loretta Anselmi, Massimo Conte, Angelo Carpi, Ferruccio Bonino
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?